The Journal of Immunology · 2010 · 93 citations · 47 references
Life SciencesImmunologyInfectious DiseasesMucosal ImmunologyVaccine ImmunologyVaccinologyMucosal Immune SystemMucosal ImmunityMucosal ImmunizationMucosal PathogenesisMucosal VaccinesSecretory Immunoglobulin AMucosal Adjuvant EffectsMucosal AntibodiesMucosal Immunity To BacteriaMucosal Vaccine ResponsesNasal Mucosal ImmunityNasal VaccinationNasal VaccinesStreptococcal Colonization
This study was designed to investigate whether secretory-IgA (S-IgA) Abs induced by a pneumococcal surface protein A (PspA)-based nasal vaccine are necessary for prevention of streptococcal colonization. Mice nasally immunized with PspA plus a plasmid expressing Flt3 ligand (pFL) cDNA as a mucosal adjuvant showed significantly higher levels of PspA-specific S-IgA and IgG Ab responses in both plasma and nasal washes when compared with naive mice. Although IgA(-/-) mice given nasal PspA plus pFL had significantly high levels of PspA-specific IgG Abs, high numbers of CFUs were detected in nasal washes and nasal passages. In contrast, vaccinated wild-type mice showed essentially no bacteria in the nasal cavity. Further, a nasal vaccine consisting of PspA plus pFL effectively reduced pre-existing Streptococcus pneumoniae in the nasal cavity. These results show that PspA-based vaccine-induced specific S-IgA Abs play a necessary role in the regulation of S. pneumoniae colonization in the nasal cavity.
47
Infectious Diseases Society of America
J. F. Enders · The Journal of Infectious Diseases · 1969 · 3.3K citations
Cynthia G. Whitney, Monica M. Farley, James L. Hadler et al. · New England Journal of Medicine · 2003 · 2.2K citations · Full text
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17